Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Yakugaku Zasshi is Scopus-indexed (Q4, CiteScore 0.6), WoS SCIE. Published by Pharmaceutical Society of Japan.
Checked against the index lists dated .
ISSN 0031-6903Verify ISSN ↗1347-5231Verify ISSN ↗
Publisher: Pharmaceutical Society of Japan
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 156 / 191 | 18th | Q4 |
| Pharmacology | 286 / 328 | 12th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1961–present, best quartile Q4, CiteScore 0.6.
Yakugaku Zasshi is Q4 in Pharmaceutical Science (rank 156 of 191) and Q4 in Pharmacology (rank 286 of 328), by CiteScore 2025.
Yakugaku Zasshi is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 0.6, which places it in quartile Q4 at the 18th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.136, quartile Q4, with an H-index of 49.
Yakugaku Zasshi is published by Pharmaceutical Society of Japan. Its print ISSN is 0031-6903 and its online ISSN is 1347-5231.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Yakugaku Zasshi has an h-index of 62 and a 2-year mean of 0.52 citations per paper (OpenAlex). Its Scopus CiteScore is 0.6, quartile Q4. On 2-year citations it ranks #133 of 177 Scopus journals in Pharmaceutical Science.
Yakugaku Zasshi published 118 papers in 2025; its busiest recent year was 2018 with 218. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 94 research articles (2026), authors are most often from Japan (97.3%), Sri Lanka (1.6%) and Germany (0.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 4 retracted papers are recorded (0.2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.